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Mononuclear phagocytes are classified as macro-
phages or dendritic cells (DCs) based on cell
morphology, phenotype, or select functional proper-
ties. However, these attributes are not absolute and
often overlap, leading to difficulties in cell-type iden-
tification. To circumvent this issue, we describe a
mouse model to define DCs based on their ontoge-
netic descendence from a committed precursor.
We show that precursors of mouse conventional
DCs, but not other leukocytes, are marked by
expression of DNGR-1. Genetic tracing of DNGR-1
expression history specifically marks cells tradition-
ally ascribed to the DC lineage, and this restriction
is maintained after inflammation. Notably, in some
tissues, cells previously thought to be monocytes/
macrophages are in fact descendants from DC pre-
cursors. These studies provide an in vivo model for
fate mapping of DCs, distinguishing them from other
leukocyte lineages, and thus help to unravel the func-
tional complexity of the mononuclear phagocyte
system.
INTRODUCTION
Dendritic cells (DCs) play a key role in immune regulation. Histor-
ically, DCs have been identified as nonlymphocytic motile cells
of dendritic morphology, expressing high levels of major histo-
compatibility complex class II molecules (MHCII) and the integrin
CD11c (Geissmann et al., 2010; Hashimoto et al., 2011; Heath
and Carbone, 2009; Steinman and Idoyaga, 2010). In addition,
functional criteria, including migratory capacity and superior
ability to stimulate T lymphocytes, are often used to distinguish
DCs from other mononuclear phagocytes such as macrophages
(MØs) and monocytes (Hashimoto et al., 2011; Milling et al.,2010; Steinman and Idoyaga, 2010). However, functional attri-
butes are not discrete cellular properties, and phenotypic
markers are often shared among related cell types, particularly
after infection or during inflammation when they are up- and
downregulated. The inability to accurately distinguish DCs and
MØs has led to confusion and debate and makes it difficult to
assess whether individual mononuclear phagocyte subtypes
have unique functions in the immune system (Hashimoto et al.,
2011; Hume, 2008).
Gene expression analysis and ontogenetic relationships have
been used to refine the definition of DCs and MØs. For instance,
two types of MØs and two subsets of DCs have been described
across lymphoid and nonlymphoid tissues of both mice and
humans by comparing gene expression signatures and/or
demonstrating that the development of a given population
depends on a specific transcription factor, cytokine, or growth
factor (Gautier et al., 2012; Geissmann et al., 2010; Greter
et al., 2012; Haniffa et al., 2012; Hashimoto et al., 2011; Heath
and Carbone, 2009; Hildner et al., 2008; Meredith et al., 2012a;
Miller et al., 2012; Persson et al., 2013; Satpathy et al., 2012;
Satpathy et al., 2011; Schlitzer et al., 2013; Schulz et al., 2012;
Tussiwand et al., 2012). Nevertheless, there remains the need
for an overarching ontogenetic definition that unifies the DC
family and establishes it as an independent leukocyte lineage
(Hashimoto et al., 2011).
Mouse bone marrow (BM) cells lacking lineage-restricted
markers (lin) and expressing CD115 (M-CSF receptor), CD135
(fms-like tyrosine kinase receptor-3), CX3CR1, and low levels
of CD117 (c-kit, stem cell factor receptor) give rise only to DCs
after in vitro culture or transfer intomice and are termed common
DC precursors (CDPs) (Auffray et al., 2009; Liu et al., 2009; Naik
et al., 2007; Onai et al., 2007). CDPs do not exit the BM but give
rise to pre-DCs, which migrate through the blood to lymphoid
and nonlymphoid organs, where they terminally differentiate
into conventional DCs (cDCs), including the two main CD11b+
and CD11b– cDC subsets (Ginhoux et al., 2009; Liu et al.,
2009; Naik et al., 2006, 2007; Onai et al., 2007). In contrast,
plasmacytoid DCs (pDCs) are thought to derive from CDPsCell 154, 843–858, August 15, 2013 ª2013 Elsevier Inc. 843
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independently of pre-DCs (Liu et al., 2009; Naik et al., 2007; Onai
et al., 2007), although their CDP origin has recently been ques-
tioned (Onai et al., 2013).
As ontogeny is immutable, the tracking of CDP and pre-DC
progeny should allow for definition of the DC lineage irrespective
ofmarkers or functional criteria. This would help resolve issues of
nomenclature within themononuclear phagocyte family and pro-
vide a system for studying DC dynamics in the steady state and
after inflammation or infection. Here, we report that precursors of
cDC can be defined in mice by expression of the C-type lectin
receptor DNGR-1 and describe a model for genetic labeling of
DNGR-1-expressing cells and their progeny that allows for onto-
genetic definition of the DC lineage in mice.
RESULTS
DNGR-1 Marks CDP and Pre-DC
DNGR-1 (also known as CLEC9A) is expressed at high levels by
CD8a+ and CD103+CD11b cDCs and at lower levels by pDCs in
mice (Caminschi et al., 2008; Poulin et al., 2012; Sancho et al.,
2008). We additionally noticed the presence of low levels of
the receptor on splenic pre-DCs, defined as lin CD11c+CD43+
CD135+CD172alow cells (Naik et al., 2006), from wild-type, but
not control DNGR-1-deficient (Clec9agfp/gfp) mice (Sancho
et al., 2009; Figure S1A available online). Pre-DCs from BM
also expressed DNGR-1 (Figure S1B). In that organ, DNGR-1+
cells were additionally found in the linCD11cCD115+ compart-
ment, which includes MØ/DC precursors (MDPs; Fogg et al.,
2006) and CDPs (Figure 1A). However, DNGR-1 expression
correlated with lower levels of CD117 (Figure 1A), a phenotype
associated with CDP activity in transfer studies (Auffray et al.,
2009; Naik et al., 2007; Onai et al., 2007). Indeed, we found un-
imodal DNGR-1 expression on CD117low, but not on CD117hi
cells or on CD117low cells from control Clec9agfp/gfp BM (Sancho
et al., 2009) (Figures 1A and S1C). The linCD11cDNGR-1+
cells additionally expressed CD135, but not CD127 (IL-7Ra), a
marker for lymphoid precursors (Schlenner et al., 2010) (data
not shown), and therefore phenotypically resembled CDPs.
To establish that DNGR-1 marks progenitors with DC-
restricted potential, we sorted linCD115+DNGR-1+ cells from
BM of CD45.1 B6.SJL mice irrespective of CD117 levels (Fig-
ure S1D; called linDNGR-1+ cells) and transferred them into un-
irradiated CD45.2 congenic hosts. Control (unfractionated) BM
gave rise to a variety of lymphoid andmyeloid lineages, including
B (B220+MHCII+), T (CD3+), and NK (NK1.1+CD3) cells, neutro-
phils/monocytes (Gr-1+CD11b+), and cDCs (CD11c+MHCII+)
(Figures 1B and 1C). In contrast, linDNGR-1+ cells generatedFigure 1. DNGR-1 Marks Cells with cDC Restricted Differentiation Pot
(A) Lin (Ter119, NK1.1, CD4, CD8, B220, CD11b, andMHCII), CD11cBM cells f
by flow cytometry. Top: DNGR-1 and CD117 expression on linCD11cC
(CD117hiCD135+) and CDP (CD117lowCD135+).
(B and C) LinCD115+DNGR-1+ cells (linDNGR-1+) or total BM from CD45.1 B
CD45.1+ donor-derived splenocytes were analyzed for expression of lineagemark
to identify CD205+CD11b DCs and CD11b+CD205 DCs. CD11clowMHCIICD4
experiments with two to three mice per group.
(D and E) CD45.1+ linCD115+DNGR-1+ (linDNGR-1+, n = 5) or total BM (n = 6)
splenic CD45.1+ cells were analyzed for CD11c and MHCII (D) or CD11c and Sig
See Figure S1.almost exclusively CD11c+MHCII+ cDCs, including both
CD11b– (also known as CD8a+, identified here by CD205 expres-
sion) and CD11b+ subsets at the expected ratio (Figures 1B and
1C; data not shown).
The progeny of linDNGR-1+ cells also included
CD11clowMHCII cells. These cells lacked the pDC markers
Gr-1, B220, or SiglecH, in contrast to CD11clowMHCII cells
derived from total BM (Figure 1C), but expressed low levels
of F4/80 and CD11b (Figure 1C), suggesting that they might
constitute pre-DCs (Naik et al., 2006). Consistent with that
notion, linDNGR-1+ BM cells gave rise exclusively to
CD11c+MHCII+ cDCs after transfer into sublethally irradiated
hosts, where an increased niche favors terminal differentiation
of the donor cells (Figure 1D). In contrast, control total BM
gave rise to multiple cell types, including pDCs (Figures 1D
and 1E). Thus, in adoptive transfers, linDNGR-1+ cells specif-
ically give rise to cDCs, but not pDCs or other lymphoid or
myeloid cells, indicating that DNGR-1marks cDC-restricted pre-
cursors. We continue to refer to the DNGR-1+CD11c precursor
as ‘‘CDP’’ even though our data would suggest that the acronym
is better expanded as ‘‘conventional DC precursor’’ (see
Discussion).
Clec9a-Cre Mice Allow Genetic Marking of CDP in BM
and Their Progeny in Lymphoid Tissues
We hypothesized that tracing the expression history of DNGR-1
would allow us to determine the ontogenetic contribution of
CDPs and pre-DCs to the mononuclear phagocyte system.
We generated mice expressing Cre recombinase under control
of the Clec9a locus by homologous recombination (Figures
S2A and S2B) and crossed them to Rosa26-stopflox-enhanced
yellow fluorescent protein (YFP) reporter mice (Srinivas et al.,
2001) (hereafter referred to as Clec9a+/+Rosa+/EYFP or
Clec9a+/creRosa+/EYFP mice, indicating the genotype at both
loci). In Clec9a+/creRosa+/EYFP mice, Cre-mediated excision of a
floxed stop codon is predicted to lead to constitutive expression
of YFP, thus irreversibly marking DNGR-1-expressing cells and
their progeny.
We first validated that Clec9a-driven Cre is active in DC
precursors. Indeed, YFP was detected in CDPs and pre-DCs,
but not MDPs of Clec9a+/creRosa+/EYFP mice, as defined
phenotypically (Figures 2A–2C). However, only a fraction of
the DC precursors was labeled, indicating that recombination
of the stop codon at the population level is incomplete
(see below). Nevertheless, we found YFP+ cells in spleen
of Clec9a+/creRosa+/EYFP, but not Clec9a+/+Rosa+/EYFP mice
(Figures 2D–2F). The majority of YFP+ splenocytes wereential
romWT, andClec9agfp/gfpmice were analyzed for CD117, CD115, and DNGR-1
D115+ cells. Bottom: DNGR-1 expression on linCD11cCD115+ MDP
6.SJL mice were transferred into unirradiated CD45.2 recipients. On day 7,
ers (B). (C) CD45.1+CD11c+MHCII+ cDCswere analyzed for CD205 and CD11b
5.1+ cells were analyzed for lineage markers. Data are representative of three
cells were transferred into sublethally irradiated CD45.2 recipients. On day 7,
lecH (E) expression.
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CD11c+MHCII+ cDCs (86.9% ± 4%), whereas a minor fraction
(1.7% ± 0.4%) resembled F4/80hi autofluorescent red pulp
MØs. The remainder was CD11clowMHCIIlow/ and included
cells expressing SiglecH, B220, and Gr-1, but not CD11b, which
resembled pDCs (Figures 2D and 2E). The YFP signal was cell
autonomous and did not result from bystander uptake of YFP+
cells or cell debris as determined by the use of mixed BM chi-
meras (Figure 2G). This was additionally supported by image
analysis showing uniform cytosolic rather than endosomal local-
ization of YFP (Figure 2H). Systematic analysis of YFP+ spleno-
cytes revealed minimal contribution of B, T, NK, and NKT cells,
neutrophils, or Ly-6Chi monocytes (Figures 2F, S2C, and S2D).
No YFP labeling of erythrocytes or nonhematopoietic cells was
observed (data not shown).
We next assessed the presence and penetrance of the YFP
signal in spleen DC subpopulations. We found that 99.1% ±
0.4% of CD8a+ cDCs were YFP+ (Figures 3A and 3B). This
high labeling efficiency is to be expected from additive effects
of Cre activity in DC precursors and in differentiated CD8a+
cDCs, which express high levels of DNGR-1 (Caminschi et al.,
2008; Sancho et al., 2009). CD11b+ cDCs lack DNGR-1 protein
or messenger RNA (mRNA) (Caminschi et al., 2008; Sancho
et al., 2009) (Figures 3A, 5E, S4B, and S4C), and any YFP labeling
must therefore have occurred during their development. Accord-
ingly, 50% ± 5.2% of CD11b+ cDCs were YFP labeled (Figures
3A and 3B), which is consistent with the incomplete penetrance
of Cre-mediated DNA recombination in CDPs and pre-DCs (see
Figures 2A–2C). Among CD11b+ spleen cDCs, ESAMhi and
ESAMlowCD11b+ subsets labeled equally (Figures S3B and
S3C), suggesting that both can be generated from CDP in the
steady state despite earlier suggestions to the contrary (Lewis
et al., 2011).
Interestingly, pDCs showed amuch lower degree of YFP label-
ing (20.6% ± 7.4%) than CD11b+ cDCs (Figures 3A and 3B) even
though they express low levels of DNGR-1 (Sancho et al., 2008).
This is consistent with our transfer data indicating that pDCs do
not descend from DNGR-1+ precursors (see Figures 1C and 1E)
and, therefore, do not have the opportunity to excise the stop
codon preceding YFP during development. A DC that lacks
CD205 expression but expresses CD8a and CX3CR1 and
resembles pDCs has recently been identified (Bar-On et al.,
2010; Edelson et al., 2010). Interestingly, 78% ± 5% of these
CD8a+CD205 plasmacytoid-like DCs (CD8a+CD205 pDCs)
were labeled with YFP (Figures 3A and 3B) even though they
express DNGR-1 at levels comparable to classical pDCs (dataFigure 2. Clec9a+/creRosa+/EYFP Mice Exhibit DC-Restricted YFP Expre
(A–C) Flow cytometry of BM from Clec9a+/+Rosa+/EYFP and Clec9a+/creRosa+
(linCD11c+CD135+, mean percentage ± SD, n = 6) (B) is shown. YFP+ gates were
of YFP+ cells in MDPs (linCD11cCD115+ CD135+CD117hi), CDPs (linCD11c
Clec9a+/creRosa+/EYFP mice.
(D–F) Flow cytometric analysis of spleen from Clec9a+/creRosa+/EYFP and Clec9
presence of F4/80hi autofluorescent (auto) red pulp MØs and CD11c+MHCII+ cDC
Gr-1, SiglecH, and B220. (F) Percentage of the indicated populations out of total Y
(G and H) Lethally irradiated mice were injected i.v. with a 1:1 mixture of CD45.1
splenic CD11c+MHCII+ cDCs were analyzed for donor BM contribution and
Stream, showing YFP signal in CD11c+CD11b+ and CD11c+CD11b splenic D
morphology (603 magnification).
See also Figure S2.not shown; Figure 3A). This high degree of YFP labeling suggests
that some CD8a+CD205 pDCs may arise from CDP (see Dis-
cussion). YFP+ cells were located in the T cell areas of the white
pulp, as well as scattered around the red pulp, mimicking the
known distribution of DCs in steady state (Figure 3C). Impor-
tantly, no YFP signal was observed in CD169+ metallophilic
MØs (Figure 3C) or in blood Ly-6Chi and Ly-6Clow monocytes,
which arise from MDP and can act as precursors of tissue
MØs (Figure S3A).
We obtained analogous results when analyzing YFP expres-
sion in CD11c+MHCII+ resident cDCs in skin-draining lymph
nodes (sdLN; Figures 3D and 3E). In sdLN, we also examined
YFP labeling among the CD11c+MHCIIhi migratory DCs (Figures
3D and 3E). CD103+ migratory cDCs displayed extensive YFP
labeling (91.5% ± 1.4%; Figures 3D and 3E), which is in line
with the fact that they express high levels of DNGR-1 (Poulin
et al., 2012). CD103CD207CD11b+ cells lack DNGR-1 expres-
sion (Poulin et al., 2012) but also labeled with YFP (41.2% ± 5%;
Figures 3D and 3E), confirming their CDP origin (Ginhoux et al.,
2009). Importantly, CD103CD207+ Langerhans cells (LCs),
which predominantly arise from embryonic precursors (Chorro
et al., 2009; Hoeffel et al., 2012), showed little YFP expression
(2.7% ± 1.1%; Figures 3D and 3E). We obtained equivalent
results in spleen and sdLN of Rosa26-stopflox-YFPmice crossed
toClec9a-Cremice generated using a bacterial artificial chromo-
some (BAC) transgenic approach (Figures S3D–S3F). In sum,
tracing the expression history of DNGR-1 reveals CDP-derived
populations in lymphoid organs and confirms the cDC-restricted
potential of DNGR-1+ precursors.
The incomplete labeling of differentiated DC populations is
most likely a direct consequence of incomplete labeling of
BM precursors in Clec9a+/creRosa+/EYFP and Clec9a-Cre BAC x
Rosa+/EYFP mice (Figure 2C; data not shown). To test this explic-
itly, we transferred YFPlinDNGR-1+ cells fromCD45.2Clec9a-
Cre BAC x Rosa+/EYFP mice into sublethally irradiated CD45.1
congenic hosts. YFPlinDNGR-1+ cells exclusively generated
cDCs in spleen, including both CD8a+ and CD11b+ cDCs at
the expected ratio (Figure S3G). Importantly and consistent
with a time lag between Cre expression and DNA recombination
(see Discussion), some YFPlinDNGR-1+ CDPs also generated
YFP+ cells (Figure S3G). Thus, the incomplete labeling of DC
precursors in Clec9a-Cre mice is stochastic and not attributable
to qualitative differences between YFP+ and YFP precursors,
supporting the suitability of the genetic model to trace CDP-
derived cells.ssion
/EYFP mice. YFP expression on linCD11cCD115+ cells (A) and pre-DCs
set on cells fromClec9a+/+Rosa+/EYFP control mice (not shown). (C) Percentage
CD115+CD135+CD117low, see Figure 1A) and pre-DCs (linCD11c+CD135+) of
a+/+Rosa+/EYFP mice. (D) Live YFP+ cells were identified and analyzed for the
s. (E) YFP+CD11clowMHCIIlow/ cells identified in (D) were further analyzed for
FP+ cells. (C and F) Horizontal bars are themean from at least two experiments.
+ B6.SJL and CD45.2+ Clec9a+/creRosa+/EYFP BM. CD11b+ and CD8a+CD205+
YFP expression 6–8 weeks later. (H) Representative images from Image
Cs from Clec9a+/creRosa+/EYFP mice. Bright-field images show dendritic cell
Cell 154, 843–858, August 15, 2013 ª2013 Elsevier Inc. 847
(legend on next page)
848 Cell 154, 843–858, August 15, 2013 ª2013 Elsevier Inc.
Lineage Tracing of CDP-Derived Cells in Nonlymphoid
Tissues Reveals Expected and Unexpected
Heterogeneity of Mononuclear Phagocytes
We additionally analyzed YFP expression in nonlymphoid tis-
sues. In all tissues examined, there was no labeling of nonhema-
topoietic CD45 cells (data not shown). YFP+CD45+ cells were
found in lungs of Clec9a+/creRosa+/EYFP mice, but not in
Clec9a+/+Rosa+/EYFP controls, with cDCs and pDCs accounting
for >95% of all YFP+ cells (Figure 4A). To assess labeling of
pulmonary DCs, we gated on CD11c+MHCII+ cells (Figure 4C)
after excluding CD11chi autofluorescent alveolar MØs, which
are YFP negative (Figure 4B). Within this gate, CD64+CD11b+
cells (Figure 4C) have been argued to represent monocyte prog-
eny (Gautier et al., 2012; Langlet et al., 2012; Plantinga et al.,
2013; Tamoutounour et al., 2012). Consistent with that notion,
CD64+CD11c+MHCII+ cells were inefficiently labeled with YFP
(5.3% ± 1%; Figures 4C and 4D). Among CD11c+MHCII+CD64
cells, there was near-complete labeling of CD103+ cDCs (97% ±
0.6%; Figures 4C and 4D), which express DNGR-1 (Desch et al.,
2011; Poulin et al., 2012), and a lower degree of labeling of
CD103CD11b and CD11b+ cells (52% ± 8.4% and 27.6% ±
2.6%, respectively; Figures 4C and 4D), which lack DNGR-1
expression (Poulin et al., 2012). As in lymphoid organs, pDCs
were inefficiently labeled (10.3% ± 3.3%, Figure 4D), despite
expressing DNGR-1 at low levels. We obtained analogous
lineage-tracing results in lungs from Clec9a-Cre BAC mice (Fig-
ure S4A). In either mouse model, we found no YFP labeling of
eosinophils, neutrophils, alveolar MØs, or Ly-6Chi monocytes
(Figures 4D and S4A).
In small intestine, CD11c+MHCII+ cells include CD64+ cells
marked by intermediate to low levels of CD11c (Figure 4E) and
high levels of CD11b (data not shown). These cells likely corre-
spond tomonocyte-derived CD11clowCX3CR1
+ cells (Bogunovic
et al., 2009; Tamoutounour et al., 2012; Varol et al., 2009) and,
accordingly, labeled poorly with YFP (6.5% ± 0.9%; Figures 4E
and 4F). The CD64 population could be subdivided into
CD103+CD11b, CD103+CD11b+, and CD103CD11b+ cells
(Figure 4E), as described (Bogunovic et al., 2009). CD103+
CD11b cDCs express DNGR-1 (Figure S4B and S4C) and
labeled extensively with YFP (96% ± 0.8%; Figures 4E and 4F).
CD11b+ cells lack DNGR-1 protein and mRNA (Figure S4B and
S4C) but labeled strongly with YFP irrespective of CD103
expression (Figures 4E and 4F), suggesting that CD103+CD11b+,
as well as CD103CD11b+ cells, can descend from CDPs.
In kidney, YFP expression encompassed MHCII+ cells with a
wide range of CD11c expression (Figure 5A). Therefore, weFigure 3. Clec9a+/creRosa+/EYFP Mice Faithfully Trace CDP-Derived Cel
(A) Live auto splenocytes from Clec9a+/creRosa+/EYFP mice were gated. YFP e
CD8a+CD205 pDCs, and CD11b+ DCs, as well as pDCs (SiglecH+B220+). Histo
(B) Percentage of YFP+ cells in the indicated populations.
(C) Immunofluorescence of YFP, CD169, and B220 in spleen from Clec9a+/+Rosa
image of box i.
(D and E) Flow cytometry of sdLN from Clec9a+/creRosa+/EYFPmice. (D) YFP expre
dermal DCs as well as CD103CD207+ LC). CD11c+MHCII+ resident DCs were s
shown. (B and E) Each dot represents onemouse. Red indicates high DNGR-1 exp
populations. Horizontal bars are the mean from at least two experiments.
See also Figure S3.gated on MHCII+CD45+ cells independently of CD11c levels
and divided them into CD64+ and CD64 populations (Fig-
ure 5B). MHCII+CD64 kidney cells expressed higher levels
of CD11c than CD64+ cells and comprised CD103+CD11b
and CD103CD11b+ subsets, as well as CD103CD11b cells
(Figure 5B). CD103+CD11b cDCs express DNGR-1 (Poulin
et al., 2012) (Figures 5E and S5A) and labeled extensively
with YFP (95% ± 3.5%; Figures 5B and 5C). CD11b+ cells
lack DNGR-1 protein or mRNA (Figures 5E and S5A) but were
also YFP labeled (33% ± 6.2%; Figures 5B and 5C). Notably,
CD103CD11b cells labeled with YFP more efficiently than
CD11b+ cells (76% ± 8%; Figures 5B, 5C, and S5B). Thus,
most CD11c+CD64MHCII+ kidney leukocytes are CDP
derived, as expected. Surprisingly, MHCII+CD64+ cells in kid-
ney labeled with YFP at frequencies similar to CD64CD11b+
DCs (29.5% ± 3.7%; Figures 5B, 5C, and S5B). Most kidney
CD64+ cells expressed low levels of CD11b and stained
strongly for F4/80, unlike in other organs (Figure 5F; see
CD45.2+ host cells). Both CD11blow and CD11bhi subpopula-
tions labeled with YFP (Figure 5D) even though they lacked
DNGR-1 protein or mRNA (Figures 5E and S5A). These data
suggest that, in kidney, CD64 expression does not differentiate
CDP-derived from monocyte-derived cells.
We confirmed the CDP origin of CD64+ kidney cells by adop-
tive transfer of linDNGR-1+ BM cells (Figure 5F). In these
experiments, most donor-derived CD64+ kidney cells were
CD11bhiF4/80int rather than CD11blowF4/80hi, even in control
mice receiving total BM (Figure 5F). CD64+CD11blowF4/80hi
cells resemble tissue-resident MØs thought to arise from yolk
sac progenitors (Schulz et al., 2012). To confirm the BM origin
of all kidney YFP+ cells, including the CD64+CD11blow cells, we
analyzed BM chimeric mice (Figures 2G, S5C, and S5D). 6 to
8 weeks after reconstitution, CD64+ cells in the kidney con-
tained both CD11bhi and CD11blow populations and, when
derived from Clec9a+/creRosa+/EYFP donors, labeled with YFP
at a frequency comparable to that of CD11b+CD64 cells
(Figures S5C and S5D). Therefore, the underrepresentation of
CD11blowF4/80hi cells following adoptive transfer of CDPs
likely reflects a timing issue or a limitation of the transplant
model. Finally, analysis of lung and small intestine populations
in the BM chimeras confirmed that YFP labeling of CD11b+
cells in all cases results from DNGR-1 expression on
BM-derived rather than embryonic precursors (Figures S5C
and S5D). This conclusion is further supported by the absence
of YFP+ cells in MØ populations from day 14 embryos (data
not shown).ls in Spleen and Lymph Node
xpression on CD11c+MHCII+ cells, subset into CD8a+ cDCs (CD8a+CD205+),
gram overlay shows DNGR-1 expression on cDCs.
+/EYFP and Clec9a+/creRosa+/EYFP mice. Bottom panel is a higher-magnification
ssion on CD11c+MHCIIhi migrating DCs (CD103+CD207+ and CD103CD207
ubset as in (A). (E) The percentage of YFP+ cells in the indicated populations is
ression, blue indicates low DNGR-1 expression, and black indicates DNGR-1
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Kidney CD64+ CDP-Derived Cells Phenotypically
and Functionally Resemble DCs
We next determined whether the unexpected CD64+ CDP prog-
eny in kidney exhibited typical characteristics of cDCs. YFP+
cells were located in the kidney tubular interstitium and showed
dendritic morphology with prominent membrane protrusions
(Figures 6A and 6B). Most YFP+ cells stained for F4/80 (Figures
6A and 6B), thus corresponding to the CD64+ cells identified
by flow cytometry (Figure 5F). We subdivided YFP+ cells
into CD64+, CD64CD11b+, and CD64CD24+ (i.e., CD11b)
populations. Notably, MHCII expression on CD64+ cells was
comparable to that on CD11b+ DCs and was slightly higher
than on CD24+ DCs (Figure 6C). When further subdivided,
CD64+CD11blowF4/80hi cells expressed higher levels of CD86
than CD64+CD11bhiF4/80low and CD64CD11b+ DCs but levels
comparable to those on CD24+ DCs (Figure 6C). In contrast,
CD40 expression was comparable across all kidney DCs.
A hallmark of DCs is the ability to process antigen and to stim-
ulate naive CD4+ T cells. We sorted YFP+CD64+CD11blowF4/80hi
cells and cultured them with CFSE-labeled OT-II T cells in the
presence or absence of ovalbumin (OVA) protein. As reference
antigen-presenting cells (APCs), we included splenic CD11b+
cDCs and B cells. Notably, kidney YFP+CD64+ cells potently
stimulated upregulation of CD25 and subsequent proliferation
of T cells (Figures 6D and 6E). B cells were inactive in the
same assay, whereas splenic CD11b+ cDCs were the most
potent APC (Figures 6D and 6E). Both kidney YFP+CD64+ cells
and spleen CD11b+ cDCs supported the differentiation of T lym-
phocytes into effector cells producing interferon-g (IFN-g) and
tumor necrosis factor-a (TNF-a; Figure 6F). Thus, YFP+CD64+
kidney leukocytes exhibit the morphological, phenotypic, and
functional attributes typically associated with cDCs.
Clec9a+/creRosa+/EYFP Mice Faithfully Trace
CDP-Derived Cells during Inflammation
Finally, we tested whether Clec9a+/creRosa+/EYFP mice can also
be used to faithfully trace CDP-derived cells during inflamma-
tion, when monocytes differentiate into cells resembling cDCs
(Geissmann et al., 2010; Hashimoto et al., 2011; Heath and
Carbone, 2009; Steinman and Idoyaga, 2010). Monocytes from
Clec9acre/creRosa+/tdRFP mice (similar to Clec9a+/creRosa+/EYFP
but encoding a variant red fluorescent protein, RFP) were
cultured in GM-CSF or GM-CSF + IL-4, conditions that are
commonly used to differentiate DC in vitro and are thought to
mimic inflammation. Notably, the output of those cultures did
not label with RFP despite phenotypically resembling DCs
(Figure S6). We then infected Clec9a+/creRosa+/EYFP mice withFigure 4. Clec9a+/creRosa+/EYFP Mice Trace CDP-Derived Cells in Lung
(A–D) Flow cytometry of lung from Clec9a+/creRosa+/EYFP mice. (A) Percentage of
on CD45+auto+ alveolar MØs. (C) Live CD45+auto cells were gated. CD11c+M
CD64 cells, CD103+CD11b/low, CD103CD11b/low, and CD103CD11b+ cells
indicated populations is shown.
(E and F) Flow cytometry of small intestine from Clec9a+/creRosa+/EYFP mice
CD64+CD11c+/int and CD64CD11chi cells. Among CD64CD11chi cells, CD10
analyzed for YFP expression. (F) Percentage of YFP+ cells in the indicated popu
(D and F) Each dot represents one mouse. Red indicates high DNGR-1 expres
populations. Horizontal bars are the mean from two experiments.
See also Figure S4.Listeria monocytogenes. 24 hr after infection, inflammatory
monocyte-derived cells (called ‘‘TipDCs’’ [Serbina et al.,
2003b]) could be identified as Gr-1+CD11blow that produce
TNF-a (Figure 7A). Importantly, these TipDCs did not label with
YFP (Figure 7A), which is in contrast to CD11c+Gr-1 cDCs
(Figure 7B).
It has been shown that monocytes can differentiate intomigra-
tory APCs capable of priming naive T cells in models of colitis
(Tamoutounour et al., 2012; Zigmond et al., 2012). We therefore
analyzed cellular infiltrates in the colon of Clec9a+/creRosa+/EYFP
mice after 5 days of oral DSS treatment. In colitic colon, DNGR-1
expression remained restricted to CD103+CD11b DCs (Fig-
ure 7C). We identified monocyte-derived cells as CD11b+
nonneutrophils expressing either Gr-1 or CD64. As reported
(Tamoutounour et al., 2012), they encompassed three pop-
ulations with varying expression levels of MHCII and Gr-1
(Figure 7D; ‘‘Mo-waterfall’’ gate). Importantly, none of these
monocyte-derived populations expressed significant levels of
YFP (Figure 7D), which is in contrast to CD11c+MHCII+CD64
cDCs (Figure 7E). Thus, Clec9a+/creRosa+/EYFP mice specifically
trace CDP, but not monocyte progeny during systemic bacterial
infection or acute intestinal inflammation.
DISCUSSION
The classification of mononuclear phagocytes as DCs or MØs is
largely based on phenotypic and/or functional criteria. This has
led to substantial confusion (Hume, 2008), especially during
infection or inflammation when many of the supposedly defining
markers and functions of DCs change profoundly (Geissmann
et al., 2010; Hashimoto et al., 2011; Heath and Carbone, 2009).
The identification of more restricted DC markers has thus far
not offered a conclusive resolution to cell type definition. For
instance, expression of Zbtb46, which distinguishes cDCs from
other lymphoid and myeloid cells, is downregulated after DC
stimulation and is additionally found on endothelial cells, early
erythroid progenitors, andmonocytes stimulatedwithGM-CSF+
IL-4 (Meredith et al., 2012a, 2012b; Satpathy et al., 2012). To
circumvent the limitations of an approach based purely on
phenotype and function, here we adopt an ontogenetic perspec-
tive to define cDCs. We show that DNGR-1 acts as a bona
fide marker of mouse cDC precursors and describe a model
in which cDCs can be faithfully identified by means of their
DNGR-1 expression history. Clec9a+/creRosa+/EYFP mice thus
provide a genetic model with which to assess the contribution
of a committed myeloid precursor to the mononuclear phago-
cyte system and can be used to define the mouse DC lineageand Small Intestine
the indicated populations out of total YFP+ cells. (B) CD64 and YFP expression
HCII+ cells were divided into CD64+ and CD64 cells. Among CD11c+MHCII+
were identified. YFP expression is shown. (D) Percentage of YFP+ cells in the
. (E) Live CD45+ cells were gated. CD11c+MHCII+ cells were divided into
3+CD11b, CD103+CD11b+, and CD103CD11b+ cells were identified and
lations.
sion, blue indicates low DNGR-1 expression, and black indicates DNGR-1
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from its first committed precursor through to the differentiated
state.
DNGR-1+ precursors did not give rise to pDCs in adoptive
transfer or genetic labeling experiments, which is consistent
with recent suggestions that pDCs arise froma distinct pDC-spe-
cificprecursor (Cisseet al., 2008;Onai et al., 2013;Satpathyet al.,
2012). Such results put in question the existence of a ‘‘common
DC precursor’’ that gives rise to cDCs and pDCs, but not mono-
cytes. For simplicity, we continue to refer to theDNGR-1+ precur-
sor as ‘‘CDP,’’ although we use this acronym to mean ‘‘conven-
tional DC precursor.’’ Intriguingly, CD8a+CD205 pDCs,
although resembling classical pDCs (Bar-On et al., 2010), were
highly labeled with YFP in our reporter mice. Thus, some
CD8a+CD205 pDCs may arise from CDP, although refined line-
age tracing systems, such as a Clec9a-driven inducible Cre
recombinase, will be needed to fully resolve the issue. Neverthe-
less, our genetic mapping analysis suggests that similarities in
gene expression and transcription factor dependence do not
always allow accurate conclusions about cell ontogeny.
Our analysis reveals the presence of CDP-derived cells
among the intestinal CD11b+CD103 mononuclear phagocyte
pool, which has previously been suggested to arise from mono-
cytes (Bogunovic et al., 2009; Varol et al., 2009). As those earlier
studies did not include the CD64 marker in their analysis, it is
conceivable that the monocyte contribution is limited to
CD103CD11b+ cells that express CD64, which likely corre-
spond to CX3CR1
hi MØs (Varol et al., 2009). Our fate mapping
analysis also reveals the existence of CDP-derived cells within
the renal mononuclear CD64+ phagocyte pool. This indicates
that CD64 expression does not always mark monocyte progeny
and is in linewith the emerging concept thatmononuclear phago-
cytes with apparently overlapping phenotype can have distinct
origins (Hashimoto et al., 2013; Hoeffel et al., 2012; Schulz
et al., 2012). Conversely, our analysis also reveals the presence
of cells with distinct phenotypes but common origin such as the
ESAMhi and ESAMlow spleen cDC populations. Altogether, these
observations raise the question of the extent to which nature
versus nurture dictates the functions of mononuclear phago-
cytes. Consistent with a dominant role for nature, YFP+CD64+
kidney cells have morphological, phenotypic, and functional
characteristics of cDCs. However, in other circumstances,
CDP-derived cells might be poor stimulators of T cells or lack
other typical features of DCs. The ability to define DCs on the
basis of ontogeny allows for investigation of typical and atypical
DC functions and will help to determine the extent to which
functions of mononuclear phagocytes are dictated by environ-
mental imprinting.Figure 5. Lineage Tracing Identifies Previously Unappreciated CDP-De
(A–D) Flow cytometry of kidney from Clec9a+/creRosa+/EYFP mice. (A) Live CD4
and CD11b expression. (B) CD45+CD11c+/lowMHCII+ cells were divided into
CD103+CD11b, CD103CD11b, and CD103CD11b+ cells were identified a
indicated populations (C) and in CD11blow and CD11bhi fractions of CD11c+/lowMH
DNGR-1+ populations, and black indicates DNGR-1 populations. Horizontal ba
(E) Clec9a mRNA expression normalized to GapDH in the indicated cell populati
(F) CD45.1+linCD115+DNGR-1+ (Figure S1D; n = 5) or total BM cells (n = 6) from
On day 7, donor-derived kidney cells were analyzed for CD11c, MHCII, and CD6
was compared to CD45.2+CD64+ host cells.
See also Figure S5.Due to the incomplete penetrance of labeling, conclusions
cannot be drawn about the lack of YFP in any given cell and,
instead, YFP needs to be considered at the level of cell popula-
tions. We believe the origins of the incomplete labeling lie in the
nature of the system rather than in DC heterogeneity. Because
of a time lag between Cre protein synthesis and DNA recombina-
tion, actively dividing DC precursors (Liu et al., 2009; Onai et al.,
2007) can dilute Cre protein before excising the floxed stop
cassette. This causes a fraction of the precursors to ‘‘escape’’
labeling in a stochastic fashion, as seen in other fate mapping
models (Jakubzick et al., 2008; Ye et al., 2003; Yona et al.,
2013). Confirming that notion, increased Cre expression (in
homozygous Clec9a-Cre mice) leads to markedly increased
labeling ofDCprecursors andnear-completemarkingof differen-
tiated cDCs (Figure S7). These data confirm that Clec9a+/cre
Rosa+/EYFP mice allow for the identification of CDP-derived pop-
ulations based onYFP labeling frequencies. The one exception is
pDCs,whichexpress low levels ofDNGR-1and inwhich thepres-
ence of YFP is not necessarily an indicator of ontogeny but of re-
ceptor expression. Should other cell types upregulate DNGR-1 in
specific circumstances, a similar caveat would apply. In such
ambiguous cases, YFP analysis may require further refinement,
such as the concomitant adoptive transfers presented here.
As shown here, Clec9a+/creRosa+/EYFP mice will be especially
useful for tracing CDP-derived cells during infection and inflam-
mation. Clec9a-Cre mice may also be used to manipulate gene
expression specifically in CDP-derived cells, opening perspec-
tives with regards to understanding the functional complexity
of the mononuclear phagocyte system. Finally, our data confirm
the notion of cDCs as an independent hematopoietic lineage
(Naik et al., 2013) and pave the way toward a revised nomencla-
ture of mononuclear phagocytes that takes cell ancestry into
account.
EXPERIMENTAL PROCEDURES
Mice
Clec9a+/cre, Clec9agfp/gfp, Rosa26-stopflox-EYFP (Srinivas et al., 2001),
Rosa26-stopflox-tdRFP (Luche et al., 2007), C57BL/6J, and B6.SJL mice
were bred at Cancer Research UK in specific pathogen-free conditions. 6-
to 10-week-old littermate control mice were used. Animal experiments were
performed in accordance with national and institutional guidelines for animal
care and approved by the London Research Institute Animal Ethics Committee
and by the UK Home Office.
Isolation of Cells
All lymphoid and nonlymphoid tissues, except bone marrow, were subjected
to enzymatic digestion with Collagenase IV (200 U/ml; Worthington) and
DNase I (0.2 mg/ml, Roche) to isolate cells for flow cytometry.rived Cells in Kidney
5+ cells were gated. YFP+ cells were analyzed for CD11c, MHCII, CD103,
CD64+CD11clow and CD64CD11chi cells. Among CD64CD11chi cells,
nd analyzed for YFP expression. (C and D) Percentage of YFP+ cells in the
CII+CD64+ cells (D; see also F). Each dot represents onemouse. Red indicates
rs are the mean from three experiments.
ons as determined by quantitative RT-PCR.
B6.SJL mice were transferred i.v. into sublethally irradiated CD45.2 recipients.
4 expression. F4/80 and CD11b expression on CD11c+/lowMHCII+CD64+ cells
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Adoptive Transfer
Magnetically enriched lin BM cells (Ter119, NK1.1, CD4, CD8, B220, MHCII,
CD11b, and CD11c) were stained for CD117, CD115, and DNGR-1 and sorted
as linCD115+DNGR-1+ cells. 8 3 104 linCD115+DNGR-1+ or 2 3 106 total
BM cells were injected intravenously (i.v.) into 3- to 4-week-old unirradiated
congenic mice. In some experiments, recipient mice were sublethally irradi-
ated (6.6 Gray) 24 hr before transfer of 6 3 104 linCD115+DNGR-1+ or 2 3
106 total BM cells.
Cell Culture
Carboxyfluorescein succinimidyl ester (CFSE)-labeled OT-II cells (5–10 3 104
cells) were cultured with APCs (titrated starting at 53 104 cells) and OVA pro-
tein (10 mg/ml) for 4 days (96 well V-bottom plates). CFSE profiles were
analyzed by flow cytometry or cells were restimulated with PMA (10 ng/ml)
and ionomycin (1 mg/ml) in the presence of Brefeldin A (5 mg/ml) for 4 hr for
intracellular cytokine staining.
2.5 3 104 BM monocytes were cultured in complete RPMI supplemented
with GM-CSF (10 ng/ml; produced at Cancer Research UK) ± IL-4 (20 ng/ml;
R&D systems) for 5 days. On day 3, half of the media was replaced with fresh
cytokine cocktail.
Image Stream
Samples were acquired on a 4-laser, six channel ISx imaging flow cytometer at
603magnification and analyzed using IDEAS5.0 (both IFC,Amnis). At least 13
105 single cells were collected using a bright-field threshold. A compensation
matrix was generated using single-color controls to perform postacquisition
spectral correction on a per pixel, per channel basis (Filby and Davies, 2012).
Microscopy
Mice were perfused with 2% paraformaldehyde (PFA)/PBS, tissues harvested
and fixed in 2% PFA/PBS for 24 hr, then incubated in 30% sucrose/H2O over-
night and frozen in OCT. 10 mmsections were air-dried, fixed (4%PFA, 10min),
washed in PBS, permeabilized (0.2% TritonX/PBS), blocked with PBS/10%
rabbit serum, 1% BSA, 0.1% Tween20 (30 min), and stained in PBS 1%
BSA, 0.1% Tween20 (1–2 hr) at room temperature. Confocal microscopy
was done on a Zeiss 710 upright microscope with 203 and 103 objectives
and analyzed with ImageJ and Bitplane Imaris software.
Mixed BM Chimeras
24hr after irradiation (twodosesof 6.6Grayseparatedby4hr),CD45.2+C57BL/
6Jmice were injected i.v. with 23 106 total BM cells at a 1:1 mixture of CD45.1
B6.SJL to CD45.2 Clec9a+/creRosa+/EYFP or CD45.1 B6.SJL to CD45.2
Clec9a+/+Rosa+/EYFP BM. Mice were analyzed 6–8 weeks after reconstitution.
Infections
Mice were infected i.v. with 5,000 CFU recombinant Listeria monocytogenes-
OVA (LM-OVA, kindly provided by Leo Lefranc¸ois). 24 hr later, splenocytes
were isolated by collagenase digestion and cultured in complete RPMI with
Brefeldin A for 4 hr, with or without heat-killed LM-OVA (HKLM, prepared by
incubation at 70C for 3 hr [Lauvau et al., 2001]) added at a 50:1 ratio of
HKLM:splenocytes (Serbina et al., 2003a).
DSS Colitis
Mice received Dextran Sulfate Sodium Salt (DSS, 2%) in drinking water
as described (Wirtz et al., 2007; Zigmond et al., 2012) and were monitored
for weight loss every day. On day 5 of DSS treatment, colons were analyzed.Figure 6. Kidney CD64+ CDP-Derived Cells Exhibit Phenotypic and Fun
(A and B) Immunofluorescence of kidney from Clec9a+/creRosa+/EYFP mice staine
architecture. Dotted line shows divide between cortex andmedulla. (B) Renal corte
(C) Expression of CD86, CD40, and MHCII on YFP+ kidney leukocytes subset in
CD64CD103+CD11b and CD64CD103CD11b cells (not shown).
(D–F) CFSE-labeled OT-II T cells were cultured with sorted splenic CD11b+ DCs
dilution profiles and CD25 expression on OT-II cells cultured with 53 104 APC. (E
day 4, OT-II T cells cultured with 53 104 APC were restimulated with PMA/ionom
intracellular staining. (E and F) Mean ± SD; n = 3, representative of three experimSUPPLEMENTAL INFORMATION
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